|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2872 USD | +0.83% |
|
+11.82% | -29.25% |
| May. 14 | Earnings Flash (INM) INMED PHARMACEUTICALS Posts Q3 Revenue $1.2M | MT |
| May. 14 | InMed Pharmaceuticals Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended March 31, 2024 | CI |
InMed Pharmaceuticals Inc. announced the appointment of Ms. Janet Grove to its Board of Directors, effective 11 February 2022. Ms. Janet Grove is a Partner at Norton Rose Fulbright Canada LLP. Contemporaneous with Ms. Grove's appointment, Catherine Sazdanoff has decided to transition off the Board of Directors for personal reasons.
Ms. Sazdanoff has served on the Board since July 2019.
| 1st Jan change | Capi. | |
|---|---|---|
| -29.25% | 1.73M | |
| +8.65% | 114B | |
| +11.27% | 104B | |
| -12.73% | 22.41B | |
| -1.05% | 22.28B | |
| -5.29% | 19.07B | |
| -38.29% | 18B | |
| -4.09% | 17.89B | |
| +7.86% | 14.28B | |
| +35.42% | 12.55B |
INMED PHARMACEUTICALS INC. 
